Amoxicillin
NDC Package 66116-477-20

11-digit billing NDC: 66116047720

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Amoxicillin is to reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. Marketed by Medvantx, Inc., this product is identified by NDC 66116-477 and is authorized under FDA application ANDA065256.

Identification & Billing

NDC Package Code
66116-477-20
Package Description
20 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
66116047720
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Amoxicillin
Dosage Form
-
Usage Information
To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.  Amoxicillin tablets, USP are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below:

Regulatory & Marketing

Labeler Name
Medvantx, Inc.
FDA Application #
ANDA065256
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-09-2005
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66116-477-20 identifies a specific commercial package of 20 tablet, film coated in 1 bottle of Amoxicillin, labeled by Medvantx, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Medvantx, Inc. on November 09, 2005. The current certification is valid through December 31, 2017.

How is this Medvantx, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66116047720. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66116-477-20
11-Digit CMS (5-4-2)
66116-0477-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.